Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA - Wikidata - wikimedia - TriplyDB

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

http://www.wikidata.org/entity/Q34433586

about

CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks A Broad Overview and Review of CRISPR-Cas Technology and Stem Cells Recent advances in innovative therapeutic approaches for Duchenne muscular dystrophy: from discovery to clinical trials Spermatogonial stem cell autotransplantation and germline genomic editing: a future cure for spermatogenic failure and prevention of transmission of genomic diseases Customizing the genome as therapy for the β-hemoglobinopathies The Rise of CRISPR/Cas for Genome Editing in Stem Cells Genome-editing Technologies for Gene and Cell Therapy Making sense of GWAS: using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genome Genome Editing and Its Applications in Model Organisms Minimizing off-Target Mutagenesis Risks Caused by Programmable Nucleases From Gene Targeting to Genome Editing: Transgenic animals applications and beyond CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases Pharmacology of manipulating lean body mass The CRISPR revolution and its impact on cancer research Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference Epigenome engineering in cancer: fairytale or a realistic path to the clinic?RNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processes Efficient Generation of Myostatin Knock-Out Sheep Using CRISPR/Cas9 Technology and Microinjection into Zygotes Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors Advances in gene therapy for muscular dystrophies Recent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian Descendants Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine The application of genome editing in studying hearing loss Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy The CRISPR system can correct or modify the expression of genes responsible for hereditary diseases Therapeutic genome editing: prospects and challenges A peptide encoded by a transcript annotated as long noncoding RNA enhances SERCA activity in muscle Severe myopathy in mice lacking the MEF2/SRF-dependent gene leiomodin-3 Efficient Restoration of the Dystrophin Gene Reading Frame and Protein Structure in DMD Myoblasts Using the CinDel Method.CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice.Animal models to improve our understanding and treatment of suicidal behavior Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo Lentiviral vectors can be used for full-length dystrophin gene therapy CRISPR/Cas9 Immune System as a Tool for Genome Engineering.Differentiation of spontaneously contracting cardiomyocytes from non-virally reprogrammed human amniotic fluid stem cells.CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.Genome-wide association study identifies candidate genes for piglet splay leg syndrome in different populations.Spell Checking Nature: Versatility of CRISPR/Cas9 for Developing Treatments for Inherited Disorders.

P2860

Q22337358-257B5D98-0C52-49F3-9CD9-B14AFAD51322 Q26741086-83798FD0-DED5-4DA0-8010-709A59D089BD Q26741371-64F5269F-7AAB-47E1-A50B-4DC24C1EE485 Q26741409-75F59ACE-DF7A-4B63-8DD7-D15FE5E7D313 Q26744780-750CFA1B-133B-4EFF-8634-1DE846513D2A Q26751061-4EABCD59-228A-4CF8-AA5F-AEBF181302FD Q26765852-E97BBCFF-9206-47C0-86EE-464E99AAD866 Q26769662-99C1B7B9-D5EA-4AD9-B1A0-1565A96953B9 Q26771497-42AAC095-1C0D-4852-A9F8-FF455C1C1B65 Q26772108-3A126020-2468-4D98-B714-2DADAE267888 Q26778992-ED9FF73E-0F53-4024-B8AF-AF0B5851E0CE Q26781859-7C04C0D9-1DF3-456E-A374-0CD241F78569 Q26799640-AD6CDA30-6A22-400E-B6F7-A8CBE921E449 Q26824503-CC0DBE68-68AB-4F1A-9432-1DB9784696BD Q26824997-0B332BF6-B034-49E1-AF65-65EA96275FF4 Q26852489-A87A728C-2811-48E3-8740-B27343583307 Q26861350-5D499EE0-6D86-475F-9028-94CA6EDF24A9 Q27025675-E19D66B7-38C5-409C-82DD-2A74BEC4286B Q27321083-540F0150-65C8-41B0-9989-501D561091E0 Q28069464-E79F6F8A-D6EF-4B33-97D6-CCD17F837529 Q28073994-2152A69C-9B23-48BC-90EA-F403E9BC8681 Q28075331-8390459F-7466-47EE-8E61-703C533266F5 Q28076397-B376BB42-1D7E-4F86-A07E-301AF7B18900 Q28081706-5AD8F5B5-7087-4561-9276-1D9C90913429 Q28084979-37D51BAB-1A23-4FC4-A6D8-9C93F9FD5CED Q28085767-68CEBF8D-A21A-4D55-8946-41748B6A48A9 Q28087380-ECAAFCDB-C54A-427D-89B5-48DFB8E69A87 Q28588509-4AA86ADC-8658-47B4-9755-936F76D55FF9 Q28975628-38506F47-06C9-4E18-AAC3-D99C74657CE1 Q30383884-C3D7E67D-4E11-4717-A026-1E62607717F7 Q30725695-6DD91937-DF3F-4487-B557-C61B18172C1B Q33558467-29824F7A-E2E4-4FDA-AE5C-BAF3E1ACE449 Q33635653-678784AB-F721-41C6-8E88-658E1D71982F Q33652566-F1D41978-BF41-4349-A516-28D0AD3F0BA5 Q33668822-D9F09E4E-985A-4D3C-A4A1-6ECC50FE6B12 Q33695238-632CD9F3-B5A2-4C40-928D-C1BCEF5D035F Q33699342-3CDC95C7-7704-453F-92AC-C648D73CD351 Q33830117-1A698D1C-847A-49A9-A4F8-23CE14B36331 Q33876945-678A0EC5-6DBA-458D-A18D-D06B1BF9104C Q34045672-C204D657-2A2A-46A9-B0CC-4DBF783DA31D

P2860

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

http://www.wikidata.org/entity/Q34433586

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

@ast

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

@en

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

@nl

type

label

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

@ast

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

@en

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

@nl

prefLabel

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

@ast

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

@en

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

@nl

P1433

Q34433586-C6B976DF-3A83-473F-B1E7-8FE22A2F293B

P1476

Q34433586-3009E3DE-5B29-4271-923A-9FC26D88224F

P2093

Q34433586-0210D3DA-2B7E-4D55-B2D8-183C43882F4A

Q34433586-2604A642-B2DD-4FBE-A70A-0AB7DACB1EA0

Q34433586-C3E3CD2D-6B1D-435C-95BF-1442B4C5EBF1

Q34433586-CA2E2EA1-1AC5-4A0C-84C4-B8E11CD74EE7

Q34433586-E0D05BC3-04D5-4F86-A69B-F9D08B9502B1

Q34433586-F3ED5518-2579-4CAE-B392-26ADA254AC52

P2860

Q34433586-012EE501-0AFE-4AC0-B2B2-0AD2731599FC

Q34433586-087631B8-552C-4393-9641-462056005695

Q34433586-22825668-785D-47C7-9146-8F31907B93E7

Q34433586-299E8208-C677-4442-8477-36AA60CC6140

Q34433586-2AA2CA3B-358D-4B70-AD49-6D642E4B9306

Q34433586-2B15275A-CC5B-43FF-B0D9-1491705C5CB2

Q34433586-31C1AB4F-C803-4E86-A6EA-AD57ECCF6659

Q34433586-35A5C0F4-62BC-48C8-A0BB-B2094F91ECC7

Q34433586-3D8DC09C-1128-4CC7-AAFC-615051160878

Q34433586-4BBAA3D2-71BF-4AAF-BE2F-BD3A48DEFCC6

P304

Q34433586-F933145B-C437-4B4E-9670-E8C2389B9519

P31

Q34433586-17762BD9-11D7-4F8F-84AF-F8D709A302A5

P356

Q34433586-D2071D14-A6FE-449C-8439-B9F37CF24172

P407

Q34433586-3CBF8BD4-B9BA-469E-AA73-73F3307B4CA4

P433

Q34433586-5AD352D5-6BAF-4D3A-BBBB-31BB921FB4B5

P478

Q34433586-A31734FF-4728-490F-88DF-C5D1FEB3A0D4

P577

Q34433586-510E6B78-01DC-4408-A019-A66120A576A7

P698

Q34433586-532E0F43-A556-473D-8CD3-F0639ADFFCFE

P921

Q34433586-080A07E0-DAFC-4BE4-8557-3AA461D65B02

P932

Q34433586-810DC567-C851-4403-84D6-3A7051E682D2

P356

SCIENCE.1254445

P1433

P1476

Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA

@en

P2093

Alex A Mireault

http://www.w3.org/2001/XMLSchema#string

Chengzu Long

http://www.w3.org/2001/XMLSchema#string

Eric N Olson

http://www.w3.org/2001/XMLSchema#string

John M Shelton

http://www.w3.org/2001/XMLSchema#string

John R McAnally

http://www.w3.org/2001/XMLSchema#string

Rhonda Bassel-Duby

http://www.w3.org/2001/XMLSchema#string

P2860

Cas9 as a versatile tool for engineering biology

RNA-guided human genome engineering via Cas9

Multiplex genome engineering using CRISPR/Cas systems

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

Development and applications of CRISPR-Cas9 for genome engineering.

Highly efficient endogenous human gene correction using designed zinc-finger nucleases

Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients

X chromosome-linked muscular dystrophy (mdx) in the mouse

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells

P304

1184-1188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCIENCE.1254445

http://www.w3.org/2001/XMLSchema#string

P407

P433

6201

http://www.w3.org/2001/XMLSchema#string

P478

345

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25123483

http://www.w3.org/2001/XMLSchema#string

P921

P932

4398027

http://www.w3.org/2001/XMLSchema#string